Top Markets
#1 bitcastle Token bitcastle Token +151.43%
#2 MarsCoin MarsCoin +70.18%
#3 Palladium Network Palladium Network +53.05%
#4 Siren Siren +28.27%
#5 edgeX edgeX +23.02%
#6 Status Status +20.93%
#7 Useless Coin Useless Coin +18.68%
#8 Bedrock Bedrock +18.28%
#9 PondCoin PondCoin +15.49%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
Coin of the day
bitcastle Token bitcastle Token
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
KemPharm, Inc. KemPharm, Inc.

KemPharm, Inc.

KMPH
Rankning i aktier #18400
KemPharm, Inc. operates as a specialized pharmaceutical firm focused on... KemPharm, Inc. operates as a specialized pharmaceutical firm focused on discovering and advancing proprietary prodrugs to tackle serious medical conditions across the United States. The company employs its innovative Ligand Activated Therapy (LAT) platform to create improved prodrug versions of medications already approved by the FDA, and also to develop prodrugs from existing compounds for potential applications in new disease indications. Its pipeline of investigational prodrugs strategically targets high-need areas such as attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) disorders, including idiopathic hypersomnia (IH). KP1077, KemPharm's leading experimental compound, is a prodrug of d-methylphenidate, known as serdexmethylphnidate, and is currently in Phase II clinical trials for the treatment of IH and narcolepsy. Additionally, the company is advancing KP879, a prodrug candidate designed to treat stimulant use disorder, which is undergoing Phase I clinical evaluation. KemPharm has also obtained FDA approval for AZSTARYS, a new once-daily ADHD treatment for patients aged six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company holds collaboration and license agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Founded in 2006, KemPharm, Inc. is headquartered in Celebration, Florida.
Aktiekurs
$5.81
Senast synkroniserad: 2023-02-28
Marknadsvärde
$200.14M
Förändring (1 dag)
-0.34%
Förändring (1 år)
0.00%
Land
US
Handel KemPharm, Inc. (KMPH)

Kategori

Healthcare
Aktiekurshistorik för KemPharm, Inc. (KMPH)
Högsta slutkurs: $5.54 den 2023-02-01

Lägsta slutkurs: $11.07 den 2015-04-01
Aktiekurshistorik för KemPharm, Inc. från 2015 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 22.80%
2022 -46.25%
2021 3,183.01%
2020 -31.88%
2019 -83.62%
2018 -39.43%
2017 8.52%
2016 -80.65%
2015 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.39 -8.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $756.41 6.58%
CH